Symbol Lookup

Tuesday May 24, 2016 1:57 AM ET. Data delayed 15 minutes.
3.16
0.07 (2.27%)
Bid/Lots
0.00/0
Ask/Lots
0.00/0
Open/Prev Close
3.10/3.09
Day Range
3.09-3.17
52-Week Range
2.69-26.34
Vol/Avg Daily Vol
9.8K/15.3K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
CombiMatrix Adds 3.5% After Some Managed Care Cos Require Genetic Testing of Fetal Tissue to Evaluate Miscarriage
2:50PM ET on Tuesday May 10, 2016 by MT Newswires
02:50 PM EDT, 05/10/2016 (MT Newswires) -- CombiMatrix (CBMX) is up 3.5% after the company says within the past two weeks some managed care companies have revised their medical policies for genetic testing of fetal tissue as medically necessary f...
CombiMatrix Comments on Additional Medical Policy Revisions to Reimburse for Recurrent Pregnancy Loss Testing
6:44AM ET on Tuesday May 10, 2016 by GlobeNewswire

CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre-implantation genetic diagnostics and screening, miscarriage analysis, prenatal and pediatric diagnostics, noted that withi...

CombiMatrix Corporation Reports First Quarter 2016 Financial and Operating Results
4:05PM ET on Wednesday May 04, 2016 by GlobeNewswire

Revenues Increase 28% to $3.0 Million on Record Reproductive Health

Genetic Screening Test Volume and Higher Average Revenue per Test

Conference Call Begins Today at 4:30 p.m. Eastern Time

CombiMatrix Corporation (NASDAQ:CB...

CombiMatrix Corporation to Release 2016 First Quarter Financial Results on May 4, 2016
6:00AM ET on Wednesday Apr 27, 2016 by GlobeNewswire

CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three months ended March 31, 2016 after market close on Wednesday, May 4, 2016. CombiMatrix management will hold an investment community conference ...

CombiMatrix Notes Two Additional Blue Cross Blue Shield Health Plans Revise Medical Policies to Reimburse for Recurrent Pregnancy Loss Testing
6:00AM ET on Tuesday Apr 26, 2016 by GlobeNewswire

CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre-implantation genetic diagnostics and screening, miscarriage analysis, prenatal and pediatric diagnostics, notes that Blue ...

Company Information

CombiMatrix Corporation is a provider of molecular diagnostic solutions. The Company specializes in pre-implantation genetic screening, miscarriage analysis, prenatal diagnosis and pediatric developmental disorders, offering deoxyribonucleic acid-based testing for the detection of genetic abnormalities, which cannot be identified through traditional methodologies. It performs genetic testing utilizing a range of cytogenomic techniques, including chromosomal microarray analysis, fluorescence in situ hybridization and karyotyping. Its prenatal and postnatal microarray focuses on diagnosing genomic syndromes associated with intellectual disability, developmental delays, congenital anomalies, dysmorphic features and autism spectrum disorders. It develops and markets its molecular testing services in approximately four markets, such as in vitro fertilization (IVF), miscarriage analysis (products of conception analysis), prenatal genetics and postnatal developmental disorders.

CONTACT INFORMATION

Headquarters310 Goddard Ste 150
IRVINE, CA, United States 92618-4617
Phone949-753-0624
Fax949-753-1504

EXECUTIVE OFFICERS

Chairman of the Board, President, Chief Executive OfficerRobert Jessup
DirectorMark McDonough
Chief Financial Officer, Treasurer, SecretaryScott Burell
Independent DirectorScott Gottlieb
Independent DirectorRobert Hoffman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$4.1MBeta0.27
Revenue (TTM)$10.7MEPS$-9.55
Shares Out.1.3MBook Value$6.93
Dividend Yield0.00%P/E--
Annual Dividend Rate0.00 USDPrice/Sales (TTM)0.4
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin-58.40%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample